8/31/2022 8:12:21 AM
Guardant Health Expands Collaboration With Merck KGaA On Oncology Therapeutics
8/4/2022 1:01:54 AM
Merck KGaA Q2 Group Net Sales Rise By 14.3% To EUR 5.6 Bln
5/23/2022 6:14:57 AM
Merck KGaA To Invest EUR 440 Mln In Two Major Life Science Projects In Ireland Over Five Years
5/12/2022 1:02:38 AM
Merck KGaA Q1 Group Sales Up 12.2% To EUR 5.2 Bln
3/3/2022 1:01:50 AM
Merck KGaA FY Sales Up 12.3% To EUR 19.7 Bln
12/17/2021 8:10:13 AM
Merck KGaA : TEPMETKO Receives Positive CHMP Opinion For Patients With Advanced NSCLC
12/8/2021 8:16:39 AM
Merck KGaA Announces Expansion Of Strategic, Corporate Venture Capital Arm M Ventures
11/17/2021 1:12:24 AM
Under Merck KGaA Terms, Imugene Will Be Sponsor Of Study And To Fund Clinical Study From Existing Budgets And Resources